146 related articles for article (PubMed ID: 31753378)
21. Complexation behavior of carboxymethyl short-chain amylose and quaternized chitosan.
Du J; Hong Y; Cheng L; Gu Z
Int J Biol Macromol; 2022 Jun; 209(Pt B):1914-1921. PubMed ID: 35500772
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone.
Tan G; Yu S; Li J; Pan W
Int J Biol Macromol; 2017 Oct; 103():941-947. PubMed ID: 28545971
[TBL] [Abstract][Full Text] [Related]
23. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
Lin Y; Sun B; Jin Z; Zhao K
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
[TBL] [Abstract][Full Text] [Related]
24. Structural characteristics and rheological properties of hydroxypropyl trimethyl ammonium chloride chitosan.
Ding L; Liu Z; Song S; Abubaker MA; Chen L; Shi J; Fan Z; Zhang J
Int J Biol Macromol; 2022 Sep; 216():312-321. PubMed ID: 35777515
[TBL] [Abstract][Full Text] [Related]
25. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
26. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.
Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S
J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554
[TBL] [Abstract][Full Text] [Related]
27. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus.
Tan H; Peng Z; Li Q; Xu X; Guo S; Tang T
Biomaterials; 2012 Jan; 33(2):365-77. PubMed ID: 22014946
[TBL] [Abstract][Full Text] [Related]
28. Palmitic acid- and cysteine-functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug.
Xie Y; Jin Z; Ma D; Yin TH; Zhao K
Bioeng Transl Med; 2023 May; 8(3):e10510. PubMed ID: 37206211
[TBL] [Abstract][Full Text] [Related]
29. Loading Effect of Chitosan Derivative Nanoparticles on Different Antigens and Their Immunomodulatory Activity on Dendritic Cells.
Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677435
[TBL] [Abstract][Full Text] [Related]
30. Self-assembled nanoparticles for cellular delivery of peptide nucleic acid using amphiphilic N,N,N-trimethyl-O-alkyl chitosan derivatives.
Liu C; Wang J; Huang S; Yu L; Wang Y; Chen H; Wang D
J Mater Sci Mater Med; 2018 Jul; 29(8):114. PubMed ID: 30019119
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
32. Atrial natriuretic peptide-conjugated chitosan-hydrazone-mPEG copolymer nanoparticles as pH-responsive carriers for intracellular delivery of prednisone.
M GA; C SK; Henry LJK; Natesan S; Kandasamy R
Carbohydr Polym; 2017 Feb; 157():1677-1686. PubMed ID: 27987883
[TBL] [Abstract][Full Text] [Related]
33. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
34. Enhanced bone tissue regeneration by antibacterial and osteoinductive silica-HACC-zein composite scaffolds loaded with rhBMP-2.
Zhou P; Xia Y; Cheng X; Wang P; Xie Y; Xu S
Biomaterials; 2014 Dec; 35(38):10033-45. PubMed ID: 25260421
[TBL] [Abstract][Full Text] [Related]
35. The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles.
Cao J; Zhang Y; Wu Y; Wu J; Wang W; Wu Q; Yuan Z
Colloids Surf B Biointerfaces; 2018 Jan; 161():508-518. PubMed ID: 29128837
[TBL] [Abstract][Full Text] [Related]
36. Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer.
Huang C; Li C; Cai J; Chen J; Wang B; Li M; Zhou W; Wang J; Zhang P; Zhang JV
Int J Nanomedicine; 2022; 17():5547-5563. PubMed ID: 36444194
[TBL] [Abstract][Full Text] [Related]
37. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
38. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
39. Self-Assembly of Soluble Chitosan Derivatives Nanoparticles for Vaccine: Synthesis, Characterization and Evaluation.
Liu J; Yu S; Qu W; Jin Z; Zhao K
Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883601
[TBL] [Abstract][Full Text] [Related]
40.
Zhao K; Gao Y; Hu G; Wang L; Cui S; Jin Z
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
